T. Rowe Price Concentrated Global Eq S
ETL0923AU
T. Rowe Price Concentrated Global Eq S ETL0923AU Strategy
The fund's strategy applies an active, core style approach to a global opportunity set to create a portfolio of high conviction investments in companies with competitive advantages positioned on the right side of secular change. Our research driven advantage integrates bottom-up fundamental research and absolute and relative risk measures with an aim to provide strong performance over a full market cycle.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.
Funds News & Analysis
funds
Chart of the Week: The role of semiliquid funds in your portfolio
Understanding their purpose, requirements and application for investors.
funds
Why this US fund manager says AI threatens to destroy company moats
Only one of the five classic moat pillars has predictive power today, says Westwood’s Adrian Helfert.
funds
Blue Owl offers a harsh lesson for semiliquid fund investors
Analyzing the saga of this US private credit BDC.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,819.40 | 9.30 | -0.11% |
| CAC 40 | 7,974.49 | 38.52 | 0.49% |
| DAX 40 | 23,730.92 | 166.91 | 0.71% |
| Dow JONES (US) | 46,993.26 | 46.85 | 0.10% |
| FTSE 100 | 10,403.60 | 85.91 | 0.83% |
| HKSE | 25,868.54 | 34.52 | 0.13% |
| NASDAQ | 22,479.53 | 105.35 | 0.47% |
| Nikkei 225 | 53,700.39 | 50.76 | -0.09% |
| NZX 50 Index | 13,199.77 | 17.54 | 0.13% |
| S&P 500 | 6,716.09 | 16.71 | 0.25% |
| S&P/ASX 200 | 8,614.30 | 4.40 | -0.05% |
| SSE Composite Index | 4,049.91 | 34.88 | -0.85% |